2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole

C237H221N23O8S — CID 158563464

About 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole

2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole (PubChem CID 158563464) has the molecular formula C237H221N23O8S and a molecular weight of 3551.59 g/mol. Its IUPAC name is 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole.

Molecular Properties

• Compound Name: 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole
• PubChem CID: 158563464
• Molecular Formula: C237H221N23O8S
• Molecular Weight: 3551.59 g/mol
• Exact Mass: 3548.73
• IUPAC Name: 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole
• SMILES: CC1(C)CN=C(c2cnc(-c3c4ccccc4c(-c4cnc(C5=NCC(C)(C)O5)cn4)c4ccccc34)cn2)O1.CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)c4ccccc34)cc2)=N1.CC1(C)CSC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)N5c5ccccc5)cc4)c4ccccc34)cc2)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NCCO5)cc4)c4ccccc34)cc2)N(c2ccccc2)C1(C)C.CC1(C)N=C(c2cnc(-c3c4ccccc4c(-c4ncc(C5=NC(C)(C)C(C)(C)O5)cn4)c4cc(-c5ccccc5)ccc34)nc2)OC1(C)C.CC1=NC(C)(C)C(C)(C)N1c1ccc(-c2c3ccccc3c(-c3ccc(C4=NC(C)(C)CO4)cc3)c3ccccc23)cc1
• InChI: InChI=1S/C44H41N3S.C42H40N6O2.C42H37N3O.C39H39N3O.C38H36N2O2.C32H28N6O2/c1-42(2)28-48-41(46-42)32-26-22-30(23-27-32)39-36-18-12-10-16-34(36)38(35-17-11-13-19-37(35)39)29-20-24-31(25-21-29)40-45-43(3,4)44(5,6)47(40)33-14-8-7-9-15-33;1-39(2)41(5,6)49-37(47-39)27-21-43-35(44-22-27)33-29-16-12-13-17-30(29)34(32-20-26(18-19-31(32)33)25-14-10-9-11-15-25)36-45-23-28(24-46-36)38-48-40(3,4)42(7,8)50-38;1-41(2)42(3,4)45(32-12-6-5-7-13-32)39(44-41)30-22-18-28(19-23-30)37-33-14-8-10-16-35(33)38(36-17-11-9-15-34(36)37)29-20-24-31(25-21-29)40-43-26-27-46-40;1-25-40-38(4,5)39(6,7)42(25)29-22-20-27(21-23-29)35-32-14-10-8-12-30(32)34(31-13-9-11-15-33(31)35)26-16-18-28(19-17-26)36-41-37(2,3)24-43-36;1-36(2)23-41-34(39-36)26-19-15-24(16-20-26)32-28-11-7-9-13-30(28)33(31-14-10-8-12-29(31)32)25-17-21-27(22-18-25)35-40-37(3,4)38(5,6)42-35;1-31(2)17-37-29(39-31)25-15-33-23(13-35-25)27-19-9-5-7-11-21(19)28(22-12-8-6-10-20(22)27)24-14-36-26(16-34-24)30-38-18-32(3,4)40-30/h7-27H,28H2,1-6H3;9-24H,1-8H3;5-25H,26-27H2,1-4H3;8-23H,24H2,1-7H3;7-22H,23H2,1-6H3;5-16H,17-18H2,1-4H3
• InChIKey: HREGKXHSJYBWSL-UHFFFAOYSA-N
• XLogP: 55.51
• TPSA: 335.00 Ų
• H-Bond Acceptors: 32
• Rotatable Bonds: 27
• Heavy Atoms: 269
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3551.59
LogP ≤ 5	55.51
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	32

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole?

The IUPAC name of 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole (CID 158563464) is 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole.

What is the SMILES notation for 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole?

The canonical SMILES for 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole is CC1(C)CN=C(c2cnc(-c3c4ccccc4c(-c4cnc(C5=NCC(C)(C)O5)cn4)c4ccccc34)cn2)O1.CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)O5)cc4)c4ccccc34)cc2)=N1.CC1(C)CSC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)C(C)(C)N5c5ccccc5)cc4)c4ccccc34)cc2)=N1.CC1(C)N=C(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NCCO5)cc4)c4ccccc34)cc2)N(c2ccccc2)C1(C)C.CC1(C)N=C(c2cnc(-c3c4ccccc4c(-c4ncc(C5=NC(C)(C)C(C)(C)O5)cn4)c4cc(-c5ccccc5)ccc34)nc2)OC1(C)C.CC1=NC(C)(C)C(C)(C)N1c1ccc(-c2c3ccccc3c(-c3ccc(C4=NC(C)(C)CO4)cc3)c3ccccc23)cc1.

What is the InChIKey of 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole?

The InChIKey is HREGKXHSJYBWSL-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H41N3S.C42H40N6O2.C42H37N3O.C39H39N3O.C38H36N2O2.C32H28N6O2/c1-42(2)28-48-41(46-42)32-26-22-30(23-27-32)39-36-18-12-10-16-34(36)38(35-17-11-13-19-37(35)39)29-20-24-31(25-21-29)40-45-43(3,4)44(5,6)47(40)33-14-8-7-9-15-33;1-39(2)41(5,6)49-37(47-39)27-21-43-35(44-22-27)33-29-16-12-13-17-30(29)34(32-20-26(18-19-31(32)33)25-14-10-9-11-15-25)36-45-23-28(24-46-36)38-48-40(3,4)42(7,8)50-38;1-41(2)42(3,4)45(32-12-6-5-7-13-32)39(44-41)30-22-18-28(19-23-30)37-33-14-8-10-16-35(33)38(36-17-11-9-15-34(36)37)29-20-24-31(25-21-29)40-43-26-27-46-40;1-25-40-38(4,5)39(6,7)42(25)29-22-20-27(21-23-29)35-32-14-10-8-12-30(32)34(31-13-9-11-15-33(31)35)26-16-18-28(19-17-26)36-41-37(2,3)24-43-36;1-36(2)23-41-34(39-36)26-19-15-24(16-20-26)32-28-11-7-9-13-30(28)33(31-14-10-8-12-29(31)32)25-17-21-27(22-18-25)35-40-37(3,4)38(5,6)42-35;1-31(2)17-37-29(39-31)25-15-33-23(13-35-25)27-19-9-5-7-11-21(19)28(22-12-8-6-10-20(22)27)24-14-36-26(16-34-24)30-38-18-32(3,4)40-30/h7-27H,28H2,1-6H3;9-24H,1-8H3;5-25H,26-27H2,1-4H3;8-23H,24H2,1-7H3;7-22H,23H2,1-6H3;5-16H,17-18H2,1-4H3.

What are the key properties of 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole?

2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole has a molecular weight of 3551.59 g/mol, XLogP of 55.51, 27 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4,5,5-tetramethyl-1,3-oxazole;2-[5-[10-[5-(5,5-dimethyl-4H-1,3-oxazol-2-yl)pyrazin-2-yl]anthracen-9-yl]pyrazin-2-yl]-5,5-dimethyl-4H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(2,4,4,5,5-pentamethylimidazol-1-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-oxazole;4,4-dimethyl-2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-5H-1,3-thiazole;2-[4-[10-[4-(4,4,5,5-tetramethyl-1-phenylimidazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;4,4,5,5-tetramethyl-2-[2-[2-phenyl-10-[5-(4,4,5,5-tetramethyl-1,3-oxazol-2-yl)pyrimidin-2-yl]anthracen-9-yl]pyrimidin-5-yl]-1,3-oxazole is sourced from PubChem (CID 158563464), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).